Abacus Parenteral Drugs Limited

abacusparenteral.com

Trading in pharmaceutical products is one of core industry in Uganda‘s economy. As the manufacturers of pharmaceutical products are very few to cater the market demand, majority of demand was met through importation. This business is growing at a rapid pace with the growth of population and export potential to neighbour countries like Kenya, Rwanda, Burundi, Congo, Sudan etc. Nonetheless the Government support by removal of taxes on imports of Pharmaceutical products, to sustain its policies of providing proper medication to people, also provided a vital support for its accelerating growth.

Related News

BUSINESS INSIGHTS

ARS PHARMACEUTICALS EXPANDS EXECUTIVE LEADERSHIP TEAM WITH ADDITION OF PHARMACEUTICAL COMMERCIALIZATION VETERANS

ARS Pharmaceuticals, Inc. | February 10, 2022

news image

ARS Pharmaceuticals, Inc., a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis, today announced the expansion of its executive leadership team with the appointments of Harris Kaplan as executive vice president, commercial strategy and Daniel Relovsky as senior vice president, sales and marketing. Mr. Kaplan and Mr. Relovsky, accomplished industry veterans with proven track r...

Read More

BUSINESS INSIGHTS

ELEMENT FURTHER EXPANDS ITS LIFE SCIENCES TESTING BUSINESS WITH ADDITIONAL PHARMACEUTICAL AND BIOTECH TESTING CAPABILITIES IN NORTH AMERICA AND EUROPE

Element Materials Technology | January 15, 2022

news image

Element Materials Technology (Element) completed its sixth life sciences-focused acquisition of 2021, with the formal completion of the acquisition of JMI Laboratories. Element has now built out its expertise and capability for pharmaceutical and biopharmaceutical customers, expanding to a team of more than 1,000 experts in 23 facilities across North America and Europe. This significant step change in pharmaceutical and medical testing capabilities from Element forms part of its b...

Read More

PHARMACY MARKET

YANGTZE RIVER PHARMACEUTICAL GROUP SELECTS TRACELINK PLATFORM FOR GLOBAL COMPLIANCE

Yangtze River Pharmaceutical, TraceLink | May 06, 2021

news image

TraceLink Inc., the leading digital network platform company, today announced that Yangtze River Pharmaceutical Group has selected TraceLink's global compliance solution to aid its plans for global growth. As the company gears up for international market expansion this year, Yangtze River Pharmaceutical Group (YRPG) will use TraceLink's multienterprise compliance applications and industry-leading digital supply network to comply with track and trace requirements in multiple markets, incl...

Read More

PHARMACY MARKET

SPOTLITE360 INTRODUCES PHARMACEUTICAL INDUSTRY INITIATIVE FOR SUPPLY CHAIN TRACKING, TRACING, AND SUSTAINABILITY

Spotlite360 | July 07, 2021

news image

SPOTLITE360 TECHNOLOGIES, INC. is happy to announce that it has started an initiative to provide tailored supply chain tracing and tracking solutions for pharmaceutical companies, for which it is now in contract discussions with pharmaceutical firms. This effort coincides with an impending regulatory shift in the USD 1.3 trillion pharmaceutical industry1 that will require companies to comply with the Drug Supply Chain Security Act (“DSCSA”), which requires the deployment of electroni...

Read More
news image

BUSINESS INSIGHTS

ARS PHARMACEUTICALS EXPANDS EXECUTIVE LEADERSHIP TEAM WITH ADDITION OF PHARMACEUTICAL COMMERCIALIZATION VETERANS

ARS Pharmaceuticals, Inc. | February 10, 2022

ARS Pharmaceuticals, Inc., a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis, today announced the expansion of its executive leadership team with the appointments of Harris Kaplan as executive vice president, commercial strategy and Daniel Relovsky as senior vice president, sales and marketing. Mr. Kaplan and Mr. Relovsky, accomplished industry veterans with proven track r...

Read More
news image

BUSINESS INSIGHTS

ELEMENT FURTHER EXPANDS ITS LIFE SCIENCES TESTING BUSINESS WITH ADDITIONAL PHARMACEUTICAL AND BIOTECH TESTING CAPABILITIES IN NORTH AMERICA AND EUROPE

Element Materials Technology | January 15, 2022

Element Materials Technology (Element) completed its sixth life sciences-focused acquisition of 2021, with the formal completion of the acquisition of JMI Laboratories. Element has now built out its expertise and capability for pharmaceutical and biopharmaceutical customers, expanding to a team of more than 1,000 experts in 23 facilities across North America and Europe. This significant step change in pharmaceutical and medical testing capabilities from Element forms part of its b...

Read More
news image

PHARMACY MARKET

YANGTZE RIVER PHARMACEUTICAL GROUP SELECTS TRACELINK PLATFORM FOR GLOBAL COMPLIANCE

Yangtze River Pharmaceutical, TraceLink | May 06, 2021

TraceLink Inc., the leading digital network platform company, today announced that Yangtze River Pharmaceutical Group has selected TraceLink's global compliance solution to aid its plans for global growth. As the company gears up for international market expansion this year, Yangtze River Pharmaceutical Group (YRPG) will use TraceLink's multienterprise compliance applications and industry-leading digital supply network to comply with track and trace requirements in multiple markets, incl...

Read More
news image

PHARMACY MARKET

SPOTLITE360 INTRODUCES PHARMACEUTICAL INDUSTRY INITIATIVE FOR SUPPLY CHAIN TRACKING, TRACING, AND SUSTAINABILITY

Spotlite360 | July 07, 2021

SPOTLITE360 TECHNOLOGIES, INC. is happy to announce that it has started an initiative to provide tailored supply chain tracing and tracking solutions for pharmaceutical companies, for which it is now in contract discussions with pharmaceutical firms. This effort coincides with an impending regulatory shift in the USD 1.3 trillion pharmaceutical industry1 that will require companies to comply with the Drug Supply Chain Security Act (“DSCSA”), which requires the deployment of electroni...

Read More